Showing 1 - 13 results of 13 for search 'Tangfeng Lv', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
Molecular subtyping dictates therapeutic response to anti-PD-L1 immunotherapy in ES-SCLC by Qianqian Zhang, Guoxin Wang, Wenjie Yan, Dong Wang, Jie Yin, Yong Song, Mingxiang Ye, Tangfeng Lv
Published 2025-05-01Get full text
Article -
5
-
6
-
7
-
8
-
9
First‐line chemoimmunotherapy for patients with small‐cell lung cancer and interstitial lung abnormality: CIP risk and prognostic analysis by Yu Li, Yuxin Jiang, Luyun Pan, Jun Yao, Shuo Liang, Yanjun Du, Dong Wang, Hongbing Liu, Fang Zhang, Qin Wang, Tangfeng Lv, Ping Zhan
Published 2024-12-01Get full text
Article -
10
-
11
-
12
Intrapleural dual blockade of IL-6 and PD-L1 reprograms CAF dynamics and the tumor microenvironment in lung cancer-associated malignant pleural effusion by Qinpei Cheng, Xueying Zuo, Zimu Wang, Wanjun Lu, Yuxin Jiang, Jiaxin Liu, Xinying Li, Qiuli Xu, Suhua Zhu, Xin Liu, Yong Song, Ping Zhan, Tangfeng Lv
Published 2025-05-01Get full text
Article -
13
LKB1 dictates sensitivity to immunotherapy through Skp2-mediated ubiquitination of PD-L1 protein in non-small cell lung cancer by Wei Liu, Dong Wang, Qing Miao, Peilin Chen, Hongbing Liu, Jiawen Lv, Jie Yin, Jian Feng, Yong Song, Tangfeng Lv, Mingxiang Ye, Wenjie Yan, Liting Lv, Sutong Zhan
Published 2024-12-01Get full text
Article